Description
NITONIV-100 Nitrofurantoin 100 mg SR | Vin Medicament
Product Description
NITONIV-100 contains Nitrofurantoin 100 mg in a sustained-release formulation. Nitrofurantoin is an antibacterial medicine used for certain urinary tract infections caused by susceptible bacteria. It works by interfering with bacterial processes, helping control susceptible bacteria in the urinary tract.
A sustained-release formulation is designed to release the active ingredient over a period of time, according to its formulation characteristics. Therefore, patients should follow the specific administration instructions provided with the approved product. NITONIV-100 should only be used when prescribed by a qualified healthcare professional.
Salt Composition
- Brand Name: NITONIV-100
- Active Ingredient: Nitrofurantoin
- Strength: 100 mg
- Formulation: Sustained Release (SR)
- Dosage Form: Tablet or capsule, as confirmed by the approved product label
- Therapeutic Category: Urinary Antibacterial
- Company: Vin Medicament
Uses and Indications
Nitrofurantoin may be prescribed for certain lower urinary tract infections, including uncomplicated bladder infections, when the bacteria are susceptible to the medicine. However, it is not suitable for every type of infection. For example, it is generally not appropriate for kidney infections or infections requiring adequate concentrations in other body tissues.
The choice of treatment depends on the patient’s symptoms, medical history, kidney function and, when necessary, urine test results. Consequently, a healthcare professional should determine whether Nitrofurantoin is suitable.
Product Features
- Contains Nitrofurantoin 100 mg.
- Sustained-release formulation, subject to confirmation from the approved label.
- Intended for prescribed treatment of selected bacterial urinary tract infections.
- Requires appropriate medical assessment and follow-up.
- Should be used according to the prescribed treatment schedule.
Precautions and Storage
Patients should inform their healthcare professional about kidney or liver problems, lung conditions, allergies, pregnancy, breastfeeding and other medicines they are taking. Nitrofurantoin can cause adverse effects, including nausea and, rarely, serious lung, liver or nerve problems. Seek medical advice promptly if breathing difficulties, persistent cough, jaundice or unusual numbness develops.
Furthermore, patients should complete treatment as directed and should not share antibiotics with others. Store the product according to its approved packaging instructions and keep it out of the reach of children.
PCD Pharma Franchise and Distribution Opportunities
Vin Medicament offers pharmaceutical products for eligible wholesalers, distributors and PCD pharma franchise associates. Businesses interested in NITONIV-100 can contact Vin Medicament to enquire about product availability, distribution arrangements and applicable business terms.
All marketing, promotion and distribution activities must comply with applicable pharmaceutical regulations and approved product information.
Important Note
This description is for general product information and business reference only. Verify the exact dosage form, sustained-release formulation, approved indications, packaging and safety details against the official product label before publication. NITONIV-100 should be used only under the guidance of a qualified healthcare professional.
